Inherited diseases and syndromes leading to aortic aneurysms and dissections

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 6, 2009, Pages 931-940

  Caglayan, Ahmet Okay ^a   Dundar, Munis ^b  

^a KAYSERI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Aneurysms; Dissections; Genetics

Indexed keywords

COLLAGEN TYPE 1; CYSTATHIONINE BETA SYNTHASE; FIBRILLIN 1; FIBULIN; FIBULIN 2; GUANOSINE TRIPHOSPHATASE; LEVO IDURONIDASE; MATRIX METALLOPROTEASE 3; MULTIDRUG RESISTANCE PROTEIN 6; MYOSIN; MYOSIN 11; POLYCYSTIN 1; POLYCYSTIN 2; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAF PROTEIN; SOS PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

AORTA ANEURYSM; AORTA DISSECTION; BICUSPID AORTIC VALVE; CHROMOSOME ANALYSIS; DIAGNOSTIC IMAGING; EHLERS DANLOS SYNDROME; GENE LOCUS; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION; HETEROZYGOTE DETECTION; HOMOCYSTINURIA; HUMAN; HURLER SYNDROME; KIDNEY POLYCYSTIC DISEASE; LOEYS DIETZ SYNDROME; MARFAN SYNDROME; MOLECULAR MECHANICS; NOONAN SYNDROME; PRIORITY JOURNAL; PSEUDO XANTHOMA ELASTICUM; REVIEW; TURNER SYNDROME;

ANEURYSM, DISSECTING; AORTIC ANEURYSM; AORTIC VALVE; EHLERS-DANLOS SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MARFAN SYNDROME; MICROFILAMENT PROTEINS; MUTATION; SYNDROME; TURNER SYNDROME;

EID: 67349174675     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.01.006     Document Type: Review

References (104)

1. Lilienfeld D.E., Gunderson P.D., Sprafka J.M., and Vargas C. Epidemiology of aortic aneurysms, I: mortality trends in the United States, 1951 to 1981. Arteriosclerosis 7 (1987) 637-643
2. Bickerstaff L.K., Pairolero P.C., Hollier L.H., Melton L.J., Van Peenen H.J., Cherry K.J., Joyce J.W., and Lie J.T. Thoracic aortic aneurysms: a population-based study. Surgery 92 (1982) 1103-1108
3. Hagan P.G., Nienaber C.A., Isselbacher E.M., Bruckman D., Karavite D.J., Russman P.L., Evangelista A., Fattori R., Suzuki T., Oh J.K., Moore A.G., Malouf J.F., Pape L.A., Gaca C., Sechtem U., Lenferink S., Deutsch H.J., Diedrichs H., Marcos y Robles J., Llovet A., Gilon D., Das S.K., Armstrong W.F., Deeb G.M., and Eagle K.A. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283 (2000) 897-903
4. Johnston K.W., Rutherford R.B., Tilson M.D., Shah D.M., Hollier L., and Stanley J.C. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13 (1991) 452-458
5. Hasham S.N., Guo D.C., and Milewicz D.M. Genetic basis of thoracic aortic aneurysms and dissections. Curr Opin Cardiol 17 (2002) 677-683
6. Lawrie G.M., Earle N., and DeBakey M.E. Long-term fate of the aortic root and aortic valve after ascending aneurysm surgery. Ann Surg 217 (1993) 711-720
7. Crawford E.S., Svensson L.G., Coselli J.S., Safi H.J., and Hess K.R. Surgical treatment of aneurysm and/or dissection of the ascending aorta, transverse aortic arch, and ascending aorta and transverse aortic arch. Factors influencing survival in 717 patients. J Thorac Cardiovasc Surg 98 (1989) 659-673 [Discussion 673-74]
8. Verloes A., Sakalihasan N., Koulischer L., and Limet R. Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 21 (1995) 646-655
9. Norrgard O., Rais O., and Angquist K.A. Familial occurrence of abdominal aortic aneurysms. Surgery 95 (1984) 650-656
10. Pyeritz R.E. The Marfan syndrome. In: Steinmann B. (Ed). Connective tissue and its heritable disorders (1993), Wiley-Liss, New York 437-468
11. Gray J.R., and Davies S.J. Marfan syndrome. J Med Genet 33 (1996) 403-408
12. Gray J.R., Bridges A.B., Faed M.J., Pringle T., Baines P., Dean J., and Boxer M. Ascertainment and severity of Marfan syndrome in a Scottish population. J Med Genet 31 (1994) 51-54
13. Roman M.J., Rosen S.E., Kramer-Fox R., and Devereux R.B. Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J Am Coll Cardiol 22 (1993) 1470-1476
14. Silverman D.I., Gray J., Roman M.J., Bridges A., Burton K., Boxer M., Devereux R.B., and Tsipouras P. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J Am Coll Cardiol 26 (1995) 1062-1067
15. De Paepe A., Devereux R.B., Dietz H.C., Hennekam R.C., and Pyeritz R.E. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62 (1996) 417-426
16. Dietz H.C., Cutting G.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson G.M., Puffenberger E.G., Hamosh A., Nanthakumar E.J., Curristin S.M., Stetten G., Meyers D.A., and Francomano C.A. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 35 (1991) 2337-2339
17. Biery N., Eldadah Z., Moore C., Stetten G., Spencer F., and Dietz H.C. Revised genomic organization of FBN1 and significance for regulated gene expression. Genomics 56 (1999) 70-77
18. Robinson P.N., Booms P., Katzke S., Ladewig M., Neumann L., Palz M., Pregla R., Tiecke F., and Rosenberg T. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat 20 (2002) 153-161
19. DePaepe A., Devereux R.B., Dietz H.C., Hennekam R.C., and Pyeritz R.E. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62 (1996) 417-426
20. Dietz H.C., and Pyeritz R.E. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 4 (1995) 1799-1809
21. Mizuguchi T., Collod-Beroud G., Akiyama T., Abifadel M., Harada N., Morisaki T., Allard D., Varret M., Claustres M., Morisaki H., Ihara M., Kinoshita A., Yoshiura K., Junien C., Kajii T., Jondeau G., Ohta T., Kishino T., Furukawa Y., Nakamura Y., Niikawa N., Boileau C., and Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36 (2004) 855-860
22. Hutchinson S., Furger A., Halliday D., Judge D.P., Jefferson A., Dietz H.C., Firth H., and Handford P.A. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?. Hum Mol Genet 12 (2003) 2269-2276
23. Collod-Beroud G., Beroud C., Black C., Boxer M., Brock D.J., Holman K.J., de Paepe A., Francke U., Grau U., Hayward C., Klein H.G., Liu W., Nuytinck L., Peltonen L., Alvarez Perez A.B., Rantamäki T., Junien C., and Boileau C. Marfan database (third edition): new mutations and new routines for the software. Nucleic Acids Res 26 (1998) 229-300
24. Booms P., Cisler J., Mathews K.R., Godfrey M., Tiecke F., Kaufmann U.C., Vetter U., Hagemeier C., and Robinson P.N. Novel exon skipping mutation in the fibrillin-1 gene: two 'hot spots' for the neonatal Marfan syndrome. Clin Genet 55 (1999) 110-117
25. Sood S., Eldadah Z.A., Krause W.L., McIntosh I., and Dietz H.C. Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet 12 (1996) 209-211
26. Hayward C., Porteous M.E., and Brock D.J. A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly. Mol Cell Probes 8 (1994) 325-327
27. Lönnqvist L., Child A., Kainulainen K., Davidson R., Puhakka L., and Peltonen L. A novel mutation of the fibrillin gene causing ectopia lentis. Genomics 19 (1994) 573-576
28. Francke U., Berg M.A., Tynan K., Brenn T., Liu W., Aoyama T., Gasner C., Miller D.C., and Furthmayr H. A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am J Hum Genet 56 (1995) 1287-1296
29. Milewicz D.M., Michael K., Fisher N., Coselli J.S., Markello T., and Biddinger A. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 94 (1996) 2708-2711
30. Dietz H.C., McIntosh I., Sakai L.Y., Corson G.M., Chalberg S.C., Pyeritz R.E., and Francomano C.A. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 17 (1993) 468-475
31. Stahl-Hallengren C., Ukkonen T., Kainulainen K., Kristofersson U., Saxne T., Tornqvist K., and Peltonen L. An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome. J Clin Invest 94 (1994) 709-713
32. Black C., Withers A.P., Gray J.R., Bridges A.B., Craig A., Baty D.U., and Boxer M. Correlation of a recurrent FBN1 mutation (R122C) with an atypical familial Marfan syndrome phenotype. Hum Mutat Suppl. (1998) S198-S200
33. Milewicz D.M., Grossfield J., Cao S.N., Kielty C., Covitz W., and Jewett T. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 95 (1995) 2373-2378
34. Zhang H., Hu W., and Ramirez F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 129 (1995) 1165-1176
35. Rongish B.J., Drake C.J., Argraves W.S., and Little C.D. Identification of the developmental marker, JB3-antigen, as fibrillin-2 and its de novo organization into embryonic microfibrous arrays. Dev Dyn 212 (1998) 461-471
36. Steinman B., Royce P., and Superti-Furga A. The Ehlers-Danlos syndrome. In: Royce P., and Steinmann B. (Eds). Connective tissue and its heritable disorders (2002), Wiley-Liss, New York 431-523
37. Beighton P., De Paepe A., Steinmann B., Tsipouras P., and Wenstrup R.J. Ehlers-Danlos syndrome: revised nosology, Villefranche, 1997. Am J Med Genet 77 (1998) 31-37
38. Junbao D., Hui Y., Bing W., Jian L., Jianguang Q., and Chaoshu T. Effect of l-arginine on collagen of high flow-induced pulmonary arterial remodelling. Circ J 69 (2005) 603-608
39. Xiaohui L., Junbao D., Lin S., Jian L., Xiuying T., Jianguang Q., Bing W., Hongfang J., and Chaoshu T. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J 69 (2005) 1418-1424
40. Dalgleish R. The human collagen mutation database 1998. Nucleic Acids Res 26 (1998) 253-255
41. Valkkila M., Melkoniemi M., Kvist L., Kuivaniemi H., Tromp G., and Ala-Kokko L. Genomic organization of the human COL3A1 and COL5A2 genes: COL5A2 has evolved differently than the other minor fibrillar collagen genes. Matrix Biol 20 (2001) 357-366
42. Pepin M., Schwarze U., Superti-Furga A., and Byers P.H. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342 (2000) 673-680
43. De Paepe A., and Malfait F. Bleeding and bruising in individuals with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol 127 (2004) 491-500
44. Oderich G.S., Panneton J.M., Bower T.C., Lindor N.M., Cherry K.J., Noel A.A., Kalra M., Sullivan T., and Gloviczki P. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg 42 (2005) 98-106
45. Kroes H.Y., Pals G., and van Essen A.J. Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a mother and son with a COL3A1 mutation and a normal collagen III protein profile. Clin Genet 63 (2003) 224-227
46. Turner H.H.A. Syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology 23 (1938) 566-574
47. Dawson-Falk K.L., Wright A.M., Bakker B., Pitlick P.T., Wilson D.M., and Rosenfeld R.G. Cardiovascular evaluation in Turner syndrome: utility of MR imaging. Australas Radiol 36 (1992) 204-209
48. Haddad H.M., and Wilkins L. Congenital anomalies associated with gonadal aplasia. Pediatrics 23 (1959) 885-902
49. Lemli L., and Smith D.W. The XO syndrome: a study of the differentiated phenotype in 25 patients. J Pediatr 63 (1963) 577-588
50. Rainier-Pope C.R., Cuningham R.D., Nada A.S., and Crigler Jr. J.F. Cardiovascular malformations in Turner's syndrome. Pediatrics 33 (1964) 919-925
51. Emerit I., De Grouchy J., Vernant P., and Corone P. Chromosomal abnormalities and congenital heart disease. Circulation 36 (1967) 886-905
52. Van der Hauwaert L.G., Fruns J.P., Doumoulin M., and Logghe N. Cardiovascular malformations in Turner's and Noonan's syndrome. Br Heart J 40 (1978) 500-509
53. Gravholt C.H. Clinical practice in Turner syndrome. Nat Clin Pract Endocrinol Metab 1 (2005) 41-52
54. Ho V.B., Bakalov V.K., Cooley M., Van P.L., Hood M.N., Burklow T.R., and Bondy C.A. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110 (2004) 1694-1700
55. Gotzsche C.O., Krag-Olsen B., Nielsen J., Sørensen K.E., and Kristensen B.O. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 71 (1994) 433-436
56. Sybert V.P. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 101 (1998) E11
57. Mazzanti L., Cacciari E., and Italian Study Group for Turner Syndrome (ISGTS). Congenital heart disease in patients with Turner's syndrome. J Pediatr 133 (1998) 688-692
58. Elsheikh M., Casadei B., Conway G.S., and Wass J.A. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 54 (2001) 69-73
59. Matura L.A., Ho V.B., Rosing D.R., and Bondy C.A. Aortic dilatation and dissection in Turner syndrome. Circulation 116 (2007) 1663-1670
60. Ward C. Clinical significance of the bicuspid aortic valve. Heart 83 (2000) 81-85, [J.I.]
61. Horne B.D., Camp N.J., Muhlestein J.B., and Cannon-Albright L.A. Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 110 (2004) 3143-3148
62. Huntington K., Hunter A.G., and Chan K.L. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 30 (1997) 1809-1812
63. Cripe L., Andelfinger G., Martin L.J., Shooner K., and Benson D.W. Bicuspid aortic valve is heritable. J Am Coll Cardiol 44 (2004) 138-143
64. Mohamed S.A., Hanke T., Schlueter C., Bullerdiek J., and Sievers H.H. Ubiquitin fusion degradation 1-like gene dysregulation in bicuspid aortic valve. J Thorac Cardiovasc Surg 130 (2005) 1531-1536
65. Mack G., and Silberbach M. Aortic and pulmonary stenosis. Pediatr Rev 21 (2000) 79-85
66. Duran A.C., Frescura C., Sans-Coma V., Angelini A., Basso C., and Thiene G. Bicuspid aortic valves in hearts with other congenital heart disease. J Heart Valve Dis 4 (1995) 581-590
67. Andelfinger G., Tapper A.R., Welch R.C., Vanoye C.G., George Jr. A.L., and Benson D.W. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71 (2002) 663-668
68. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., and Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 437 (2005) 270-274
69. Mohamed S.A., Aherrahrou Z., Liptau H., Erasmi A.W., Hagemann C., Wrobel S., Borzym K., Schunkert H., Sievers H.H., and Erdmann J. Novel missense mutations (p. T596M and p. P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem Biophys Res Commun 345 (2006) 1460-1465
70. Edwards W.D., Leaf D.S., and Edwards J.E. Dissecting aortic aneurysm associated with congenital bicuspid aortic valve. Circulation 57 (1978) 1022-1025
71. Roberts C.S., and Roberts W.C. Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol 17 (1991) 712-716
72. Gersony W.M., Hayes C.J., Driscoll D.J., Keane J.F., Kidd L., O'Fallon W.M., Pieroni D.R., Wolfe R.R., and Weidman W.H. Second natural history study of congenital heart defects. Quality of life of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 87 (1993) I52-165
73. Lamas C.C., and Eykyn S.J. Bicuspid aortic valve: a silent danger: analysis of 50 cases of infective endocarditis. Clin Infect Dis 30 (2000) 336-341
74. Loscalzo M.L., Goh D.L., Loeys B., Kent K.C., Spevak P.J., and Dietz H.C. Familial thoracic aortic dilation and bicommissural aortic valve: a prospective analysis of natural history and inheritance. Am J Med Genet A 143 (2007) 1960-1967
75. Coady M.A., Davies R.R., Roberts M., Goldstein L.J., Rogalski M.J., Rizzo J.A., Hammond G.L., Kopf G.S., and Elefteriades J.A. Familial patterns of thoracic aortic aneurysms. Arch Surg 134 (1999) 361-367
76. Hasham S.N., Lewin M.R., Tran V.T., Pannu H., Muilenburg A., Willing M., and Milewicz D.M. Nonsyndromic genetic predisposition to aortic dissection: a newly recognized, diagnosable, and preventable occurrence in families. Ann Emerg Med 43 (2004) 79-82
77. Milewicz D.M., Chen H., Park E.S., Petty E.M., Zaghi H., Shashidhar G., Willing M., and Patel V. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol 82 (1998) 474-479
78. Vaughan C.J., Casey M., He J., Veugelers M., Henderson K., Guo D., Campagna R., Roman M.J., Milewicz D.M., Devereux R.B., and Basson C.T. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 103 (2001) 2469-2475
79. Guo D., Hasham S., Kuang S.Q., Vaughan C.J., Boerwinkle E., Chen H., Abuelo D., Dietz H.C., Basson C.T., Shete S.S., and Milewicz D.M. Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103 (2001) 2461-2468
80. Kakko S., Raisanen T., Tamminen M., Airaksinen J., Groundstroem K., Juvonen T., Ylitalo A., Uusimaa P., and Savolainen M.J. Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5q13-14 in Finnish families. J Thorac Cardiovasc Surg 126 (2003) 106-113
81. Hasham S.N., Willing M.C., Guo D.C., Muilenburg A., He R., Tran V.T., Scherer S.E., Shete S.S., and Milewicz D.M. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107 (2003) 3184-3190
82. Boileau C., Jondeau G., Babron M.C., Coulon M., Alexandre J.A., Sakai L., Melki J., Delorme G., Dubourg O., Bonaïti-Pellié C., Bourdarias J.P., and Junien C. Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet 53 (1993) 46-54
83. Collod G., Babron M.C., Jondeau G., Coulon M., Weissenbach J., Dubourg O., Bourdarias J.P., Bonaïti-Pellié C., Junien C., and Boileau C. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet 8 (1994) 264-268
84. Loeys B.L., Chen J., Neptune E.R., Judge D.P., Podowski M., Holm T., Meyers J., Leitch C.C., Katsanis N., Sharifi N., Xu F.L., Myers L.A., Spevak P.J., Cameron D.E., De Backer J., Hellemans J., Chen Y., Davis E.C., Webb C.L., Kress W., Coucke P., Rifkin D.B., De Paepe A.M., and Dietz H.C. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37 (2005) 275-281
85. Pannu H., Fadulu V.T., Chang J., Lafont A., Hasham S.N., Sparks E., Giampietro P.F., Zaleski C., Estrera A.L., Safi H.J., Shete S., Willing M.C., Raman C.S., and Milewicz D.M. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112 (2005) 513-520
86. Disabella E., Grasso M., Marziliano N., Schmidtke J., and Arslan-Kirchner M. Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. Eur J Hum Genet 14 (2006) 34-38
87. Ades L.C., Sullivan K., Biggin A., Haan E.A., Brett M., Holman K.J., Dixon J., Robertson S., Holmes A.D., Rogers J., and Bennetts B. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am J Med Genet A 140 (2006) 1047-1058
88. Ki C.S., Jin D.K., Chang S.H., Kim J.E., Kim J.W., Park B.K., Choi J.H., Park I.S., and Yoo H.W. Identification of a novel TGFBR2 gene mutation in a Korean patient with Loeys-Dietz aortic aneurysm syndrome; no mutation in TGFBR2 gene in 30 patients with classic Marfan's syndrome. Clin Genet 68 (2005) 561-563
89. Glancy D.L., Wegmann M., and Dhurandhar R.W. Aortic dissection and patent ductus arteriosus in three generations. Am J Cardiol 87 (2001) 813-815
90. Khau Van Kien P., Wolf J.E., Mathieu F., Zhu L., Salve N., Lalande A., Bonnet C., Lesca G., Plauchu H., Dellinger A., Nivelon-Chevallier A., Brunotte F., and Jeunemaitre X. Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity. Eur J Hum Genet 12 (2004) 173-180
91. Khau Van Kien P., Mathieu F., Zhu L., Lalande A., Betard C., Lathrop M., Brunotte F., Wolf J.E., and Jeunemaitre X. Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. Circulation 112 (2005) 200-206
92. Zhu L., Vranckx R., Van Kien P.K., Lalande A., Boisset N., Mathieu F., Wegman M., Glancy L., Gasc J.M., Brunotte F., Bruneval P., Wolf J.E., Michel J.B., and Jeunemaitre X. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 38 (2006) 343-349
93. Collod G., Chu M.L., Sasaki T., Coulon M., Timpl R., Renkart L., Weissenbach J., Jondeau G., Bourdarias J.P., Junien C., and Boileau C. Fibulin-2: genetic mapping and exclusion as a candidate gene in Marfan syndrome type 2. Eur J Hum Genet 4 (1996) 292-295
94. Zhang R.Z., Pan T.C., Zhang Z.Y., Mattei M.G., Timpl R., and Chu M.L. Fibulin-2 (FBLN2): human cDNA sequence, mRNA expression, and mapping of the gene on human and mouse chromosomes. Genomics 22 (1994) 425-430
95. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90 (2002) 520-530
96. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21492-21494
97. Hannas A.R., Pereira J.C., Granjeiro J.M., and Tjäderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 65 (2007) 1-13
98. Verstappen J., and Von den Hoff J.W. Tissue Inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral diseases. J Dent Res 85 (2006) 1074-1084
99. Yoon S., Tromp G., Vongpunsawad S., Ronkainen A., Juvonen T., and Kuivaniemi H. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265 (1999) 563-568
100. Medley T.L., Kingwell B.A., Gatzka C.D., Pillay P., and Cole T.J. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 92 (2003) 1254-1261
101. Germain D.P. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis 2 (2007) 32
102. Lin A.E., Lippe B., and Rosenfeld R.G. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 102 (1998) 12
103. Lin A.E., Lippe B.M., Geffner M.E., Gomes A., Lois J.F., Barton C.W., Rosenthal A., and Friedman W.F. Aortic dilatation, dissection and rupture in patients with Turner syndrome. J Pediatr 109 (1986) 820-826
104. Biddinger A., Rocklin M., Coselli J., and Milewicz D.M. Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 25 (1997) 506-511